Tyrosine Phosphorylation of c-Maf Enhances the Expression of IL-4 Gene

Maf proteins are involved in a variety of biological processes, such as oncogenesis, lens development, and differentiation. In immune system, c-Maf transactivates IL-4 promoter, and ectopic expression of c-Maf skews primary T cell response toward the Th2 pathway. Numerous transcription factors are subjected to posttranslational modification. In this study, to our knowledge, we show for the first time that c-Maf is subjective to tyrosine phosphorylation in Th cells and that the level of its tyrosine phosphorylation positively correlates with IL-4 expression by peripheral Th cells, but is negatively associated with the severity of disease in NOD mice. c-Maf undergoes tyrosine phosphorylation at Tyr21, Tyr92, and Tyr131 residues in Th2 cells. Furthermore, tyrosine phosphorylation at these three residues is critical for the recruitment of c-Maf to IL-4 promoter and IL-4 production in Th cells. Taken together, this study sheds new light on the role of posttranslational modification of c-Maf in IL-4 production and Th cell-mediated autoimmune diseases.

[1]  Anuradha Ray,et al.  Cyclic AMP Activates p38 Mitogen-Activated Protein Kinase in Th2 Cells: Phosphorylation of GATA-3 and Stimulation of Th2 Cytokine Gene Expression1 , 2000, The Journal of Immunology.

[2]  I. Ho,et al.  SUMOylation attenuates c‐Maf‐dependent IL‐4 expression , 2010, European journal of immunology.

[3]  Y. Mo,et al.  SUMO Conjugation Contributes to Immune Deviation in Nonobese Diabetic Mice by Suppressing c-Maf Transactivation of IL-41 , 2009, The Journal of Immunology.

[4]  R. Tisch,et al.  Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. , 1999, Journal of immunology.

[5]  R. Davis,et al.  Regulation of transcription factor function by phosphorylation , 2000, Cellular and Molecular Life Sciences CMLS.

[6]  U. Baumann,et al.  An efficient one-step site-directed and site-saturation mutagenesis protocol. , 2004, Nucleic acids research.

[7]  B. Graves,et al.  Role of Ets‐1 phosphorylation in the effector function of Th cells , 2008, European journal of immunology.

[8]  Christian Schindler,et al.  Stat1 and SUMO modification. , 2006, Blood.

[9]  K. Kataoka,et al.  Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family , 1993, Journal of virology.

[10]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[11]  Irun R Cohen,et al.  Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens , 1997, Diabetes.

[12]  A. Eychène,et al.  GSK-3-mediated phosphorylation enhances Maf-transforming activity. , 2007, Molecular cell.

[13]  Sang‐Myeong Lee,et al.  c-Abl-Mediated Tyrosine Phosphorylation of the T-bet DNA-Binding Domain Regulates CD4+ T-Cell Differentiation and Allergic Lung Inflammation , 2011, Molecular and Cellular Biology.

[14]  Pamela L. Schwartzberg,et al.  T Helper Cell Fate Specified by Kinase-Mediated Interaction of T-bet with GATA-3 , 2005, Science.

[15]  V. Kuchroo,et al.  The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells , 2009, Nature Immunology.

[16]  L. Sistonen,et al.  PDSM, a motif for phosphorylation-dependent SUMO modification. , 2006, Proceedings of the National Academy of Sciences of the United States of America.